期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?
1
作者 Benoit Souchet Mickael Audrain +3 位作者 Baptiste Billoir Laurent Lecanu Satoru Tada jérome braudeau 《Neural Regeneration Research》 SCIE CAS CSCD 2018年第2期224-225,共2页
Alzheimer's disease (AD) is the most frequent cause of dementia in the western world. In clinical terms, AD is characterized by progres- sive cognitive decline that usually begins with memory impairment. As the dis... Alzheimer's disease (AD) is the most frequent cause of dementia in the western world. In clinical terms, AD is characterized by progres- sive cognitive decline that usually begins with memory impairment. As the disease progresses, AD inevitably affects all intellectual functions including executive functions, leading to complete dependence for basic activities of daily life and premature death. 展开更多
关键词 AD Is it time to rethink the Alzheimer’s disease drug development strategy by targeting its silent phase
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部